WNT974
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for WNT974, covering 2016-09-30 to 2017-10-09. Get the full timeline:
Most recent: Clinical Trial Update: Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations [Phase 1, Phase 2]